about
CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating CellsHypermethylation and down-regulation of DLEU2 in paediatric acute myeloid leukaemia independent of embedded tumour suppressor miR-15a/16-1.Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspectsmiRNAs and cancer: an epigenetics view.MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.Global epigenetic regulation of microRNAs in multiple myeloma.Regulation of coagulation factor XI expression by microRNAs in the human liverThe 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemiaEpigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasionCUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascade.MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.Mechanisms of epigenetic deregulation in lymphoid neoplasms.MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.Long non-coding RNAs in haematological malignancies.The Role of miRNA in Haematological Malignancy.Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction.DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas.Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology.Epigenetic modifications in pediatric acute lymphoblastic leukemia.MicroRNAs in the pathogenesis of myelodysplastic syndromes and myeloid leukaemiaMicroRNA: an important regulator in acute myeloid leukemia.Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia.Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.Low miR-34c expression is associated with poor outcome in de novo acute myeloid leukemia.Regulatory effects of miRNA on gastric cancer cells.MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia.MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.Epigenetic repression of miR-375 is the dominant mechanism for constitutive activation of the PDPK1/RPS6KA3 signalling axis in multiple myeloma.MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells.Circulating miRNA is a novel marker for head and neck squamous cell carcinoma.
P2860
Q28084610-AC759C3D-A500-450F-8DF4-DC7227BE35DAQ33729914-7D888DB8-D96A-4D16-A7D9-D641FE782CDBQ33801377-38E5071F-C9BA-4E1C-AE60-F08E88B65EB8Q34286618-67562FA4-EF3E-4356-B8F7-D0464F55FB34Q34309924-94EE11AC-FB20-4F82-9EF1-7CA885605D4AQ35350129-054C8220-9430-40F3-9C91-AED0D5556F68Q35402898-39C25581-1E3D-4717-BE21-DE7F21698D08Q35853830-FF62B2ED-4DF5-44E1-8733-C1AA72C65A0DQ36187865-E364C29E-7628-4726-AB6C-6A5CC66007B1Q36695607-6A37732B-3E13-42F5-BAD5-19B79152BC31Q36862518-50696EB2-1D32-4579-8871-1DD763F0E55FQ36873265-C564A33C-190B-42B1-9F85-96B97886AE71Q36890980-0EA2B301-27BD-41CB-8DF4-E7B3896F9459Q37139037-7E4EE126-3EBD-45EE-A5AB-523479C255D6Q37422388-6C21F85E-BCD7-4385-9B0A-A68C8991692FQ38038647-9089115F-CFB6-43D6-8073-6AFF2284B30CQ38060723-A8320924-5CDE-49A5-A122-E15E23B12500Q38152226-D0B1191A-1D0D-4C3A-86BF-38E620971392Q38214773-960D1F50-CA80-42D9-90FF-98A4EB313C1FQ38215614-B85ADC55-294D-4A53-92F0-619B8917619BQ38735859-ACB39143-F919-4992-B1B8-EF8751C320BEQ38847748-49928434-0EFA-4907-BCC2-8E35A787E426Q39120062-5AA16AF8-8BA3-48E9-B387-7AFBE7DF1CB3Q39137683-335206BE-72C4-4BF2-854A-54045F5149C7Q39191770-8ACDF1A5-5FF4-48C3-9550-3021E0FDF642Q40601089-A41F78E6-3196-4DCA-96EA-39EFBA7C77C2Q41893722-EEB76F31-EEC9-40E9-885D-402D864C6BAFQ43850689-C4ACA5DD-649B-46CC-B57E-A99E639BB738Q47113848-36F60AAA-FAD0-41B3-9AC9-077395ADB4D8Q48236958-26C5D47D-3624-42BB-8B5D-6C605B1F4A11Q49521797-CB4701BA-4EED-421E-A395-7560B500651BQ52725331-D0A13E3C-3251-4738-9C7A-BFAE3638E3C0Q54300178-48539776-8E40-4E12-984E-0C6598C24EE1
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic regulation of miRNA genes in acute leukemia.
@en
Epigenetic regulation of miRNA genes in acute leukemia.
@nl
type
label
Epigenetic regulation of miRNA genes in acute leukemia.
@en
Epigenetic regulation of miRNA genes in acute leukemia.
@nl
prefLabel
Epigenetic regulation of miRNA genes in acute leukemia.
@en
Epigenetic regulation of miRNA genes in acute leukemia.
@nl
P2860
P356
P1433
P1476
Epigenetic regulation of miRNA genes in acute leukemia
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2011.344
P577
2011-12-06T00:00:00Z